Message Font: Serif | Sans-Serif
No. of Recommendations: 0
I am wondering if anybody else is interested in Rhone Poulenc. I became aware of this stock from John Dessauer's Investor's World. Anybody have any comments?

In today's news: The U.S. Federal Trade Commission said it had approved the application of Novartis AG and CHIRON CORP to license certain gene therapy technologies to RHONE POULENC RORER INC. Licensing of the technology is required under an April 1997 consent order settling charges that the merger of Ciba-Geigy and Sandoz to form Novartis would reduce competition in the gene therapies for cancer and other diseases. "The licensing requirement is designed to restore competition for the development and commercialization of gene therapy treatments for cancer and (other diseases)," the FTC said in a statement.
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.